ASND

Ascendis Pharma A/S

Phase 3 AI-extracted

TransCon CNP + TransCon hGH

pediatric achondroplasia

Resolved

7days ago

Phase 3 readout · ~ Jun 30, 2026 estimated

What's at stake Phase 3 trial results for TransCon CNP + TransCon hGH in pediatric achondroplasia are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 6-K verified 15h ago

“Planned new trials to support TransCon CNP + TransCon hGH treatment in additional indications, such as hypochondroplasia.”

Add to calendar Post on X Reddit

Provenance